サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1428206

腫瘍学および免疫学におけるフローサイトメトリーの世界市場レポート 2024

Flow Cytometry In Oncology And Immunology Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
腫瘍学および免疫学におけるフローサイトメトリーの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

腫瘍学および免疫学におけるフローサイトメトリーの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.0%の年間複合成長率（CAGR）で30億7,000万米ドルに成長すると予想されます。予測期間で予想される成長は、ゲノミクスとプロテオミクスとの統合、単細胞解析の採用増加、感染症における応用の拡大、がん発生率の増加、ポイントオブケアフローサイトメトリーの出現によるものと考えられます。予測期間中に予想される注目すべき動向には、免疫療法のための免疫表現型検査、フローサイトメトリーシステムの小型化、マルチパラメータ分析、スペクトルフローサイトメトリーへの移行、および共同調査イニシアチブが含まれます。

がん罹患率の予想される増加により、腫瘍学および免疫学におけるフローサイトメトリーの成長が促進される見込みです。制御されない細胞増殖を特徴とする一連の疾患であるがんは、がんや免疫細胞の研究においてフローサイトメトリーの重要な焦点となっている分野です。たとえば、Macmillan Cancer Supportは2022年 10月に、2020年には約300万人ががんに罹患していると報告し、予測では2025年までに350万人、2030年までに400万人、2040年までに530万人に増加すると推定されています。これは、腫瘍学および免疫学におけるフローサイトメトリーの成長を推進する重要な要因です。

HIV/AIDSの有病率の増加は、腫瘍学および免疫学におけるフローサイトメトリー市場の拡大に寄与すると予想されます。 HIVは免疫系に影響を及ぼすウイルスであり、世界の健康問題を引き起こしています。フローサイトメトリーは、物理的および化学的特性に基づいて細胞、特に免疫細胞を分析することにより、HIV/AIDS調査および臨床応用において重要な役割を果たします。 2023年 7月の時点で、世界保健機関は、2022年には約3,900万人がHIVとともに生きており、その範囲は推定3,310万人から4,570万人であると報告しています。同じ期間に、HIV関連の原因で約63万人が死亡し、信頼区間は48万～88万人でした。さらに、2022年には約130万人がHIVに感染し、その範囲は100万人から170万人でした。したがって、HIV/AIDSの有病率の上昇は、腫瘍学および免疫学におけるフローサイトメトリーの成長の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の腫瘍学および免疫学におけるフローサイトメトリーの市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の腫瘍学および免疫学におけるフローサイトメトリーの市場規模実績と成長、2018年から2023年
  • 世界の腫瘍学および免疫学におけるフローサイトメトリー市場規模と成長予測、2023年から2028年、2033年

第6章 市場セグメンテーション

  • 世界の腫瘍学および免疫学におけるフローサイトメトリー、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 免疫学
  • 腫瘍学
  • 世界の腫瘍学および免疫学におけるフローサイトメトリー、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 細胞ベース
  • ビーズベース
  • 世界の腫瘍学および免疫学におけるフローサイトメトリー、アプリケーション別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • トランスレーショナル調査
  • 臨床調査
  • 世界の腫瘍学および免疫学におけるフローサイトメトリー、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 診断研究所
  • リファレンスラボ
  • 製薬会社およびバイオテクノロジー会社
  • 学術調査機関
  • 受託調査機関
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の腫瘍学および免疫学におけるフローサイトメトリー、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の腫瘍学および免疫学におけるフローサイトメトリー、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 腫瘍学および免疫学におけるフローサイトメトリーの競合情勢
  • 腫瘍学および免疫学におけるフローサイトメトリーの企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Becton Dickinson and Company
    • Laboratory Corporation of America Holdings

第31章 その他の大手および革新的な企業

  • Agilent Technologies Inc.
  • Sartorius AG
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Sysmex Partec GmbH
  • OPKO Health Inc.
  • Miltenyi Biotec
  • NeoGenomics Laboratories Inc.
  • Luminex Corporation
  • Q2 Solutions LLC
  • Enzi Biochem Inc.
  • DiaSorin SpA
  • BioLegend Inc.
  • Cytek Biosciences Inc.
  • Cell Signaling Technology Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14050

Flow cytometry, as applied in oncology and immunology, denotes a technology and methodology utilized to analyze and characterize cells based on their physical and chemical attributes.

The primary categories of flow cytometry in oncology and immunology encompass immunology and oncology. Immunology, a field within biomedical science, explores the immune system and its reactions to foreign substances referred to as antigens. Within the realms of oncology and immunology, flow cytometry involves diverse technologies, including cell-based flow cytometry and bead-based flow cytometry. These technologies find applications in various contexts such as translational research and clinical research. The end users of flow cytometry in this context encompass hospitals, diagnostic laboratories, reference laboratories, pharmaceutical and biotechnology companies, academic research institutes, contract research organizations, among others.

The flow cytometry in oncology and immunology research report is one of a series of new reports from The Business Research Company that provides flow cytometry in oncology and immunology market statistics, including the flow cytometry in oncology and immunology industry's global market size, regional shares, competitors with flow cytometry in oncology and immunology market share, detailed flow cytometry in oncology and immunology market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry in oncology and immunology industry. This flow cytometry in oncology and immunology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $1.89 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be credited to progress in cancer research, expansion in immunology research, diagnostic applications, an increase in autoimmune diseases, and the undertaking of drug development and clinical trials.

The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period can be ascribed to the integration with genomics and proteomics, the increasing adoption of single-cell analysis, the broadening applications in infectious diseases, the rise in cancer incidence, and the emergence of point-of-care flow cytometry. Notable trends expected in the forecast period include immunophenotyping for immunotherapy, the miniaturization of flow cytometry systems, multiparametric analysis, a shift towards spectral flow cytometry, and collaborative research initiatives.

The anticipated rise in cancer prevalence is poised to drive the growth of flow cytometry in the oncology and immunology market. Cancer, a group of disorders characterized by uncontrolled cell growth, is a significant area of focus for flow cytometry in studying cancer and immune cells. For example, Macmillan Cancer Support reported in October 2022 that approximately 3 million people had cancer in 2020, and projections estimate an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the increasing prevalence of cancer is a key factor propelling the growth of flow cytometry in the oncology and immunology markets.

The growing prevalence of HIV/AIDS is expected to contribute to the expansion of the flow cytometry market in oncology and immunology. HIV, a virus affecting the immune system, poses a global health challenge. Flow cytometry plays a crucial role in HIV/AIDS research and clinical applications by analyzing cells, especially immune cells, based on their physical and chemical properties. As of July 2023, the World Health Organization reported that approximately 39.0 million individuals were living with HIV in 2022, with an estimated range of 33.1 to 45.7 million. During the same period, around 630,000 people died due to HIV-related causes, with a confidence interval of 480,000 to 880,000. Moreover, approximately 1.3 million people contracted HIV in 2022, with a range of 1.0 to 1.7 million. Thus, the rising prevalence of HIV/AIDS is a significant driver for the growth of flow cytometry in the oncology and immunology market.

Technological advancements stand out as a prominent trend gaining traction in the flow cytometry market for oncology and immunology. Major players in this market are actively embracing innovative technologies to solidify their market positions. For example, in September 2022, Becton Dickinson and Company, a US-based medical technology provider, introduced the BD Research Cloud tailored for flow cytometry applications in oncology and immunology. This cloud-based software simplifies the flow cytometry process for researchers in fields such as immunology, virology, infectious disease, and oncology surveillance. Leveraging technologies such as BD Horizon RealYellow and RealBlue Reagents, along with the BD FACSDiscover S8 Cell Sorter featuring BD CellView Image Technology, BD aims to enhance flow cytometry capabilities, enabling researchers to optimize and advance their studies. BD Research Cloud, built on an industry-standard cloud infrastructure, is designed to complement BD equipment and reagents.

Companies in the flow cytometry market for oncology and immunology are also concentrating on innovative solutions such as automated sample preparation systems. An automated sample preparation system streamlines and automates various steps involved in preparing samples for analysis. For instance, in March 2022, Beckman Coulter Life Sciences, a US-based life science company, unveiled 'CellMek SPS,' a fully automated sample preparation system designed for clinical flow cytometry. This system offers on-demand processing for diverse sample types, enabling laboratories to expand their capabilities. CellMek SPS, building on a robust history of lab automation, integrates features that enhance efficiency by automating outdated manual preparation methods. This innovative system ensures a seamless workflow, delivering a continuous output of samples ready for analysis with complete traceability.

In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, completed the acquisition of Luminex Corporation for $1.8 billion. This strategic move by DiaSorin S.p.A. aims to strengthen its existing portfolio in the life science sector, fostering access to academic and scientific research, expanding collaboration with biopharma businesses, and enhancing overall market presence. Luminex Corporation, a US-based biotechnology company, specializes in providing flow cytometry solutions for oncology and immunology.

Major companies operating in the flow cytometry in oncology and immunology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason.

North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the flow cytometry in oncology and immunology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The flow cytometry in oncology and immunology market includes revenues earned by entities by providing services such as cell-based assay services, drug development services, and minimal residual disease (MRD) monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The flow cytometry in oncology and immunology market also consists of sales of products flow cytometers, fluorescence-activated cell sorters (FACS), monoclonal antibodies, and fluorochromes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flow Cytometry In Oncology And Immunology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on flow cytometry in oncology and immunology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flow cytometry in oncology and immunology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The flow cytometry in oncology and immunology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Immunology; Oncology
  • 2) By Technology: Cell-Based Flow Cytometry; Bead-Based Flow Cytometry
  • 3) By Application: Translational Research; Clinical Research
  • 4) By End User: Hospitals; Diagnostic Laboratories; Reference Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Contract Research Organizations; Other End Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton Dickinson and Company; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Flow Cytometry In Oncology And Immunology Market Characteristics

3. Flow Cytometry In Oncology And Immunology Market Trends And Strategies

4. Flow Cytometry In Oncology And Immunology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Flow Cytometry In Oncology And Immunology Market Size and Growth

  • 5.1. Global Flow Cytometry In Oncology And Immunology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Flow Cytometry In Oncology And Immunology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Flow Cytometry In Oncology And Immunology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Flow Cytometry In Oncology And Immunology Market Segmentation

  • 6.1. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunology
  • Oncology
  • 6.2. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry
  • 6.3. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Translational Research
  • Clinical Research
  • 6.4. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Reference Laboratories
  • Pharmaceutical And Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Other End Users

7. Flow Cytometry In Oncology And Immunology Market Regional And Country Analysis

  • 7.1. Global Flow Cytometry In Oncology And Immunology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Flow Cytometry In Oncology And Immunology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Flow Cytometry In Oncology And Immunology Market

  • 8.1. Asia-Pacific Flow Cytometry In Oncology And Immunology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Flow Cytometry In Oncology And Immunology Market

  • 9.1. China Flow Cytometry In Oncology And Immunology Market Overview
  • 9.2. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Flow Cytometry In Oncology And Immunology Market

  • 10.1. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Flow Cytometry In Oncology And Immunology Market

  • 11.1. Japan Flow Cytometry In Oncology And Immunology Market Overview
  • 11.2. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Flow Cytometry In Oncology And Immunology Market

  • 12.1. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Flow Cytometry In Oncology And Immunology Market

  • 13.1. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Flow Cytometry In Oncology And Immunology Market

  • 14.1. South Korea Flow Cytometry In Oncology And Immunology Market Overview
  • 14.2. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Flow Cytometry In Oncology And Immunology Market

  • 15.1. Western Europe Flow Cytometry In Oncology And Immunology Market Overview
  • 15.2. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Flow Cytometry In Oncology And Immunology Market

  • 16.1. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Flow Cytometry In Oncology And Immunology Market

  • 17.1. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Flow Cytometry In Oncology And Immunology Market

  • 18.1. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Flow Cytometry In Oncology And Immunology Market

  • 19.1. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Flow Cytometry In Oncology And Immunology Market

  • 20.1. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Flow Cytometry In Oncology And Immunology Market

  • 21.1. Eastern Europe Flow Cytometry In Oncology And Immunology Market Overview
  • 21.2. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Flow Cytometry In Oncology And Immunology Market

  • 22.1. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Flow Cytometry In Oncology And Immunology Market

  • 23.1. North America Flow Cytometry In Oncology And Immunology Market Overview
  • 23.2. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Flow Cytometry In Oncology And Immunology Market

  • 24.1. USA Flow Cytometry In Oncology And Immunology Market Overview
  • 24.2. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Flow Cytometry In Oncology And Immunology Market

  • 25.1. Canada Flow Cytometry In Oncology And Immunology Market Overview
  • 25.2. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Flow Cytometry In Oncology And Immunology Market

  • 26.1. South America Flow Cytometry In Oncology And Immunology Market Overview
  • 26.2. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Flow Cytometry In Oncology And Immunology Market

  • 27.1. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Flow Cytometry In Oncology And Immunology Market

  • 28.1. Middle East Flow Cytometry In Oncology And Immunology Market Overview
  • 28.2. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Flow Cytometry In Oncology And Immunology Market

  • 29.1. Africa Flow Cytometry In Oncology And Immunology Market Overview
  • 29.2. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Flow Cytometry In Oncology And Immunology Market Competitive Landscape And Company Profiles

  • 30.1. Flow Cytometry In Oncology And Immunology Market Competitive Landscape
  • 30.2. Flow Cytometry In Oncology And Immunology Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Flow Cytometry In Oncology And Immunology Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Sartorius AG
  • 31.3. Beckman Coulter Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Sysmex Partec GmbH
  • 31.6. OPKO Health Inc.
  • 31.7. Miltenyi Biotec
  • 31.8. NeoGenomics Laboratories Inc.
  • 31.9. Luminex Corporation
  • 31.10. Q2 Solutions LLC
  • 31.11. Enzi Biochem Inc.
  • 31.12. DiaSorin S.p.A
  • 31.13. BioLegend Inc.
  • 31.14. Cytek Biosciences Inc.
  • 31.15. Cell Signaling Technology Inc.

32. Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking

33. Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market

35. Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis

  • 35.1 Flow Cytometry In Oncology And Immunology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Flow Cytometry In Oncology And Immunology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Flow Cytometry In Oncology And Immunology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer